FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3389811000001109: Dovobet ointment (LEO Pharma) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17249101000001110 Dovobet ointment (LEO Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17249201000001115 Dovobet ointment (LEO Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dovobet ointment (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Is a Betamethasone dipropionate 0.05% / Calcipotriol 0.005% ointment true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has active ingredient Calcipotriol hydrate false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Is a Dovobet true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has specific active ingredient Calcipotriol hydrate false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has active ingredient Betamethasone true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has active ingredient Calcipotriol true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has specific active ingredient Calcipotriol hydrate false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has specific active ingredient Calcipotriol monohydrate false Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) Has specific active ingredient Calcipotriol hydrate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dovobet ointment (LEO Pharma) 120 gram Is pack of False Dovobet ointment (LEO Pharma) Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 60 gram Is pack of False Dovobet ointment (LEO Pharma) Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 60 gram Has AMP True Dovobet ointment (LEO Pharma) Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 120 gram Has AMP True Dovobet ointment (LEO Pharma) Inferred relationship Existential restriction modifier
Dovobet ointment (LEO Pharma) 30 gram Has AMP True Dovobet ointment (LEO Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start